𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia

✍ Scribed by Dr. Gary Schiller; Myung Lee; Mary Territo; James Gajewski; Stephen Nimer

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
488 KB
Volume
43
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I study of VP-16 (etoposide) and a
Phase I study of VP-16 (etoposide) and amsacrine (AMSA) in the treatment of refractory acute leukemia
✍ Letendre, Louis ;Hinemann, Vicky ;Hoagland, H. Clark ;Kovach, John S. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 291 KB

Fourteen patients with refractory acute nonlymphocytic leukemia were entered into a doseseeking trial of combination therapy with etoposide and amsacrine given daily for five consecutive days. There were three complete responses lasting 2 months, 3 months, and 10 months and two transient partial rem

Tyrosine kinase inhibitors for the treat
Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
✍ Pier Paolo Piccaluga; Stefania Paolini; Giovanni Martinelli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract Acute lymphoblastic leukemia (ALL) is a heterogeneous disorder, with the greatest prevalence in children, but it also affects adults, and has an increasing incidence with age. Chromosomal abnormalities in ALL have been frequently described, the most common is the Philadelphia chromosome

Ifosfamide/etoposide combination in the
Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II study
✍ Faith H. Kung; Charles B. Pratt; Roger A. Vega; Norman Jaffe; Douglas Strother; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 509 KB

Background. The prognosis for children with recurrent or resistant malignant solid tumors remains dismal. More effective rescue therapy is needed for these children. Methods. Between August 1987 and November 1990, 311 children with recurrent or resistant malignant solid tumors were treated by inves

Mitoxantrone-containing regimen for trea
Mitoxantrone-containing regimen for treatment of childhood acute leukemia AML and analysis of prognostic factors: Results of the EORTC Children Leukemia Cooperative Study 58872
✍ BΓ©har, Catherine; Suciu, Stefan; Benoit, Yves; Robert, Alain; Vilmer, Etienne; B πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 505 KB

The objective of this study was to evaluate the feasibility, the toxicity and the efficiency of a BFM-like treatment protocol for acute nonlymphoblastic leukemia (ANLL) of children in which mitoxantrone was substituted for conventional anthracycline. The chemotherapy called for induction (mitoxantro